OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
NOCNYSE$582.9468

NORTHROP GRUMMAN CORP /DE/

Aerospace & DefenseVerified

Northrop Grumman operates with a debt-to-equity ratio of 0.89, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as high, but its current ratio of 1.15 is near the minimum comfort range, and net cash is negative after subtracting total debt. The company's market capitalization is $83.07 billion, with a price-to-earnings ratio of 94.94, suggesting a high valuation relative to earnings. Profitability metrics show a return on equity of 5.11% and a return on assets of 1.75%, both below the industry median for Aerospace & Defense firms. The company's operating margin is 9.99% (calculated from operating income of $989 million on revenue of $9.88 billion), which is also below the industry median. This suggests that Northrop Grumman is underperforming in terms of capital efficiency and profitability compared to its peers. The company's revenue is distributed across four segments: Aeronautics Systems, Defense Systems, Mission Systems, and Space Systems. Aeronautics Systems is the largest segment, with a focus on military aircraft for the U.S. Air Force and Navy. The company's geographic exposure is primarily to the U.S. government, with international customers playing a smaller role. The concentration of revenue in the U.S. government introduces a risk of political and budgetary volatility. Northrop Grumman's growth trajectory is supported by the expansion of the B-21 program and the development of advanced missile systems such as the Stand-In Attack Weapon (SiAW) and Hypersonic Attack Cruise Missile (HACM). The company's capital expenditure of $167 million in Q1 2026 reflects ongoing investment in production capacity. However, the company's free cash flow is negative at -$1.82 billion, indicating that it is not generating sufficient cash to fund operations and growth without external financing. The company faces several risk factors, including potential changes in defense spending, government priorities, and geopolitical tensions. The risk assessment indicates a medium level of dilution potential, with source documents mentioning dilution or offering risk. The company's liquidity risk is high due to the current ratio being near the minimum comfort range and negative net cash after debt. Recent events include the Air Force's decision to expand production capacity for the B-21 program and the development of new missile systems. The company also reported a decrease in the effective tax rate (ETR) to 15.0% in Q1 2026, primarily due to higher research credits. These developments suggest a focus on long-term growth and innovation, but also highlight the company's dependence on government contracts and the potential for regulatory and budgetary changes.

30-day price · NOC-161.33 (-22.6%)
Low$544.10High$728.00Close$551.99As of14 May, 00:00 UTC
Profile
CompanyNORTHROP GRUMMAN CORP /DE/
ExchangeNYSE
TickerNOC
CIK0001133421
SICSearch, Detection, Navigation, Guidance, Aeronautical Sys
SectorIndustrials
BusinessIndustrial Goods
Industry groupIndustrial Goods
IndustryAerospace & Defense
AI analysis

Business. Northrop Grumman Corporation designs, develops, and produces military aircraft, missile defense systems, and space systems for the U.S. government and international customers.

Classification. Northrop Grumman is classified in the Aerospace & Defense industry under the Industrials sector with a confidence level of 0.92.

Northrop Grumman operates with a debt-to-equity ratio of 0.89, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as high, but its current ratio of 1.15 is near the minimum comfort range, and net cash is negative after subtracting total debt. The company's market capitalization is $83.07 billion, with a price-to-earnings ratio of 94.94, suggesting a high valuation relative to earnings. Profitability metrics show a return on equity of 5.11% and a return on assets of 1.75%, both below the industry median for Aerospace & Defense firms. The company's operating margin is 9.99% (calculated from operating income of $989 million on revenue of $9.88 billion), which is also below the industry median. This suggests that Northrop Grumman is underperforming in terms of capital efficiency and profitability compared to its peers. The company's revenue is distributed across four segments: Aeronautics Systems, Defense Systems, Mission Systems, and Space Systems. Aeronautics Systems is the largest segment, with a focus on military aircraft for the U.S. Air Force and Navy. The company's geographic exposure is primarily to the U.S. government, with international customers playing a smaller role. The concentration of revenue in the U.S. government introduces a risk of political and budgetary volatility. Northrop Grumman's growth trajectory is supported by the expansion of the B-21 program and the development of advanced missile systems such as the Stand-In Attack Weapon (SiAW) and Hypersonic Attack Cruise Missile (HACM). The company's capital expenditure of $167 million in Q1 2026 reflects ongoing investment in production capacity. However, the company's free cash flow is negative at -$1.82 billion, indicating that it is not generating sufficient cash to fund operations and growth without external financing. The company faces several risk factors, including potential changes in defense spending, government priorities, and geopolitical tensions. The risk assessment indicates a medium level of dilution potential, with source documents mentioning dilution or offering risk. The company's liquidity risk is high due to the current ratio being near the minimum comfort range and negative net cash after debt. Recent events include the Air Force's decision to expand production capacity for the B-21 program and the development of new missile systems. The company also reported a decrease in the effective tax rate (ETR) to 15.0% in Q1 2026, primarily due to higher research credits. These developments suggest a focus on long-term growth and innovation, but also highlight the company's dependence on government contracts and the potential for regulatory and budgetary changes.
Key takeaways
  • Northrop Grumman has a high valuation (P/E of 94.94) but underperforms in profitability and capital efficiency compared to industry medians.
  • The company's liquidity is high, but its current ratio is near the minimum comfort range, and net cash is negative after debt.
  • Revenue is heavily concentrated in U.S. government contracts, introducing political and budgetary risks.
  • The company is investing in production capacity for the B-21 program and developing advanced missile systems, indicating a focus on long-term growth.
  • The risk assessment highlights medium dilution potential and high liquidity risk.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodQ1 2026
CurrencyUSD
Revenue$9.88B
Gross profit
Operating income$989.0M
Net income$875.0M
R&D
SG&A$971.0M
D&A$372.0M
SBC$20.0M
Operating cash flow-$1.66B
CapEx$167.0M
Free cash flow-$1.82B
Total assets$50.01B
Total liabilities$32.89B
Total equity$17.11B
Cash & equivalents$2.09B
Long-term debt$14.41B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY2025$41.95B$4.51B$4.18B$3.31B
FY2024$41.03B$4.37B$4.17B$2.62B
FY2025$41.03B$4.37B$4.17B$2.62B
FY2023$39.29B$2.54B$2.06B$2.10B
FY2024$39.29B$2.54B$2.06B$2.10B
PeriodGross %Op %Net %FCF %
FY2025
FY2024
FY2025
FY2023
FY2024
PeriodAssetsEquityCashDebt
FY2025$51.38B$16.67B$4.40B
FY2024$49.36B$15.29B
FY2025$49.36B$15.29B$4.35B
FY2023$46.54B$14.79B$3.11B
FY2024$46.54B$14.79B
PeriodOCFCapExFCFSBC
FY2025$4.76B$1.45B$3.31B$119.0M
FY2024$4.39B$1.77B$2.62B$101.0M
FY2025$4.39B$1.77B$2.62B$101.0M
FY2023$3.88B$1.77B$2.10B$87.0M
FY2024$3.88B$1.77B$2.10B$87.0M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
Q1 2026$9.88B$989.0M$875.0M-$1.82B
Q1 2026
Q3 2025$30.24B$3.24B$2.75B$72.0M
Q2 2025$19.82B$2.00B$1.66B-$1.18B
PeriodGross %Op %Net %FCF %
Q1 2026
Q1 2026
Q3 2025
Q2 2025
PeriodAssetsEquityCashDebt
Q1 2026$50.01B$17.11B$2.09B
Q1 2026$51.38B$16.67B$4.40B
Q3 2025$49.30B$15.99B$1.96B
Q2 2025$49.45B$15.47B$1.90B
PeriodOCFCapExFCFSBC
Q1 2026-$1.66B$167.0M-$1.82B$20.0M
Q1 2026
Q3 2025$860.0M$788.0M$72.0M$65.0M
Q2 2025-$697.0M$487.0M-$1.18B$40.0M
Valuation
Market price$582.94
Market cap$83.07B
Enterprise value$96.15B
P/E94.9
Reported non-GAAP P/E
EV/Revenue9.7
EV/Op income97.2
EV/OCF
P/B
P/Tangible book
Tangible book-$532.0M
Net cash-$13.08B
Current ratio1.1
Debt/Equity0.9
ROA1.8%
ROE5.1%
Cash conversion-1.9%
CapEx/Revenue1.7%
SBC/Revenue0.2%
Asset intensity0.2
Dilution ratio0.3%
Risk assessment
Dilution riskMedium
Liquidity riskHigh
  • Current ratio is close to the minimum comfort range.
  • Net cash is negative after subtracting total debt.
  • Source documents mention dilution or offering risk.
Industry benchmarks
Activity: Aerospace & Defense · cohort 6 companies
MetricNOCActivity
Op margin10.0%4.8% medp25 0.2% · p75 11.7%above median
Net margin8.9%2.5% medp25 -1.2% · p75 9.3%above median
Gross margin16.0% medp25 5.1% · p75 29.5%
R&D / revenue2.7% medp25 0.4% · p75 4.0%
CapEx / revenue1.7%3.3% medp25 2.7% · p75 3.8%bottom quartile
Debt / equity89.0%53.2% medp25 37.6% · p75 76.6%top quartile
Observations
IR observations
Mean price target723.09 USD
Median price target743.50 USD
High price target815.00 USD
Low price target607.00 USD
Mean recommendation2.28 (1=strong buy, 5=strong sell)
Strong-buy count4.00
Buy count10.00
Hold count11.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate27.98 USD
Last actual EPS26.34 USD
Source: analysis-pipeline (hybrid)Generated: 2026-05-01 03:45 UTCJob: 5a03f450